Relationship of Clinicopathologic Parameters to MVD
| CD31-MVD* | CD105-MVD* | |||||||
|---|---|---|---|---|---|---|---|---|
| Parameter | Low | Moderate | High | P | Low | Moderate | High | P |
| Age | 0.042 | 0.254 | ||||||
| ≤65 | 10 | 9 | 3 | 11 | 5 | 6 | ||
| >65 | 4 | 9 | 10 | 6 | 8 | 9 | ||
| Sex | 0.049 | 0.376 | ||||||
| Male | 10 | 5 | 6 | 6 | 6 | 9 | ||
| Female | 4 | 13 | 7 | 11 | 7 | 6 | ||
| Stage | 0.223 | 0.004 | ||||||
| I | 11 | 13 | 7 | 16 | 9 | 6 | ||
| II, III | 3 | 2 | 5 | 0 | 3 | 7 | ||
| Size | 0.234 | 0.031 | ||||||
| ≤3 cm | 8 | 14 | 11 | 16 | 9 | 8 | ||
| >3 cm | 6 | 4 | 2 | 1 | 4 | 7 | ||
| Histologic findings | 0.017 | 0.007 | ||||||
| BAC | 0 | 8 | 4 | 9 | 2 | 1 | ||
| Non-BAC | 14 | 10 | 9 | 8 | 11 | 14 | ||
↵* Data are reported as number of tumors.
Non-BAC = well-differentiated adenocarcinoma, moderately differentiated adenocarcinoma, and poorly differentiated adenocarcinoma.